Skip to content

A Comparative study of Kadamba Ghrita And Povidone-Iodine Ointment in The Management Of Non healing Ulcer(Dushta Vrana)

A Clinoco Comparative Study Of Kadamba Ghrita And Povidone-Iodine Ointment In The Management Of Dushta Vrana (Non-Healing Ulcer)- An Open label Randomized Comparative Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098918
Enrollment
30
Registered
2025-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified Health Condition 2: L989- Disorder of the skin and subcutaneous tissue, unspecified Health Condition 3: L989- Disorder of the skin and subcutaneous tissue, unspecified Health Condition 4: L989- Disorder of the skin and subcutaneous tissue, unspecified Health Condition 5: L989- Disorder of the skin and subcutaneous tissue, unspecified Health Condition 6: L989- Disorder of the skin and subcutaneous tissue, unspecif

Interventions

None listed

Sponsors

Goverment Akhandanand Ayurved College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients will be selected irrespective of caste, gender and religion Patients clinically diagnosed with venous ulcer, Diabetic ulcer, Arterial ulcer Wounds that fail to heal within 4 weeks. Wounds of bacterial origin, including infected traumatic wounds. Patients suffering from any active infectious disease like Hepatitis, AIDS, and Tuberculosis, Leprosy.

Exclusion criteria

Exclusion criteria: Patients with serious systemic illness like Chronic Kidney Disease, Cirrhosis of Liver, Leukemia. Patients presenting with pre-gangrenous or gangrenous symptoms. Pre diagnosed case of Osteomyelitis. Patients presenting with pressure ulcers located on plantar surfaces of foot. Individuals with malignant or suspected malignant ulcer. Individuals with fractures involving movable joints near or associated with wound site

Design outcomes

Primary

MeasureTime frame
To break the pathogenesis and progression of non healing ulcer and reduction in subjective criteria like pain, itching and improvement in objective criteria like size, edge, slough, tenderness, smell etc.Timepoint: 21 days

Secondary

MeasureTime frame
To Improve quality of life of PatientTimepoint: 21 days

Countries

India

Contacts

Public ContactDrJigna Patel

Goverment Akhandand Ayurvedic College And Hospital

drjignajaypatel@gmail.com9512307475

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026